- Home
- CCEL
as of 12-08-2025 1:22pm EST
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | OLDSMAR |
| Market Cap: | 35.8M | IPO Year: | 1997 |
| Target Price: | N/A | AVG Volume (30 days): | 3.8K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.57 - $8.86 | Next Earning Date: | 10-15-2025 |
| Revenue: | $31,747,500 | Revenue Growth: | -0.29% |
| Revenue Growth (this year): | 0.3% | Revenue Growth (next year): | -4.87% |
Stock Insider Trading Activity of Cryo-Cell International Inc. (CCEL)
Chairman, Co-CEO
Avg Cost/Share
$4.48
Shares
5,162
Total Value
$23,075.05
Owned After
827,344
Chairman, Co-CEO
Avg Cost/Share
$4.43
Shares
5,564
Total Value
$24,648.52
Owned After
827,344
SEC Form 4
Chairman, Co-CEO
Avg Cost/Share
$4.46
Shares
6,449
Total Value
$28,762.54
Owned After
827,344
SEC Form 4
Chairman, Co-CEO
Avg Cost/Share
$4.45
Shares
32,317
Total Value
$143,418.51
Owned After
827,344
Chairman, Co-CEO
Avg Cost/Share
$4.49
Shares
5,312
Total Value
$23,849.32
Owned After
827,344
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| PORTNOY DAVID | CCEL | Chairman, Co-CEO | Sep 18, 2025 | Buy | $4.48 | 5,162 | $23,075.05 | 827,344 | |
| PORTNOY DAVID | CCEL | Chairman, Co-CEO | Sep 17, 2025 | Buy | $4.43 | 5,564 | $24,648.52 | 827,344 | |
| PORTNOY DAVID | CCEL | Chairman, Co-CEO | Sep 16, 2025 | Buy | $4.46 | 6,449 | $28,762.54 | 827,344 | |
| PORTNOY DAVID | CCEL | Chairman, Co-CEO | Sep 10, 2025 | Buy | $4.45 | 32,317 | $143,418.51 | 827,344 | |
| PORTNOY DAVID | CCEL | Chairman, Co-CEO | Sep 9, 2025 | Buy | $4.49 | 5,312 | $23,849.32 | 827,344 |
Compare CCEL vs Leading Stocks
See how CCEL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CCEL Cryo-Cell International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.